BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 10813531)

  • 1. In vitro generation of dendritic cells from human blood monocytes in experimental conditions compatible for in vivo cell therapy.
    Cao H; Vergé V; Baron C; Martinache C; Leon A; Scholl S; Gorin NC; Salamero J; Assari S; Bernard J; Lopez M
    J Hematother Stem Cell Res; 2000 Apr; 9(2):183-94. PubMed ID: 10813531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro production of dendritic cells from human blood monocytes for therapeutic use.
    Garderet L; Cao H; Salamero J; Vergé V; Tisserand E; Scholl S; Gorin NC; Lopez M
    J Hematother Stem Cell Res; 2001 Aug; 10(4):553-67. PubMed ID: 11522238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of dendritic cells from adherent cells of cord blood by culture with granulocyte-macrophage colony-stimulating factor, interleukin-4, and tumor necrosis factor-alpha.
    Zheng Z; Takahashi M; Narita M; Toba K; Liu A; Furukawa T; Koike T; Aizawa Y
    J Hematother Stem Cell Res; 2000 Aug; 9(4):453-64. PubMed ID: 10982243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of autologous serum on CD34(+) or monocyte-derived dendritic cells.
    Loudovaris M; Hansen M; Suen Y; Lee SM; Casing P; Bender JG
    J Hematother Stem Cell Res; 2001 Aug; 10(4):569-78. PubMed ID: 11522239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Large-scale immunomagnetic selection of CD14+ monocytes to generate dendritic cells for cancer immunotherapy: a phase I study.
    Babatz J; Röllig C; Oelschlägel U; Zhao S; Ehninger G; Schmitz M; Bornhäuser M
    J Hematother Stem Cell Res; 2003 Oct; 12(5):515-23. PubMed ID: 14594508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular and functional characteristics of dendritic cells generated from highly purified CD14+ peripheral blood monocytes.
    Pickl WF; Majdic O; Kohl P; Stöckl J; Riedl E; Scheinecker C; Bello-Fernandez C; Knapp W
    J Immunol; 1996 Nov; 157(9):3850-9. PubMed ID: 8892615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of CMRF-44+ monocyte-derived dendritic cells: insights into phenotype and function.
    Vuckovic S; Fearnley DB; Mannering SI; Dekker J; Whyte LF; Hart DN
    Exp Hematol; 1998 Dec; 26(13):1255-64. PubMed ID: 9845382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Replicative response, immunophenotype, and functional activity of monocyte-derived versus CD34(+)-derived dendritic cells following exposure to various expansion and maturational stimuli.
    Chen B; Stiff P; Sloan G; Kash J; Manjunath R; Pathasarathy M; Oldenburg D; Foreman KE; Nickoloff BJ
    Clin Immunol; 2001 Feb; 98(2):280-92. PubMed ID: 11161986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dendritic cell culture: a simple closed culture system using ficoll, monocytes, and a table-top centrifuge.
    Celluzzi CM; Welbon C
    J Hematother Stem Cell Res; 2003 Oct; 12(5):575-85. PubMed ID: 14594514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of serotonin on the differentiation of human monocytes into dendritic cells.
    Katoh N; Soga F; Nara T; Tamagawa-Mineoka R; Nin M; Kotani H; Masuda K; Kishimoto S
    Clin Exp Immunol; 2006 Nov; 146(2):354-61. PubMed ID: 17034589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological characteristics of dendritic cells derived from peripheral blood of patients with epithelial ovarian cancer.
    Lan CY; Liu JH; Xia JC; Zheng LM
    Ai Zheng; 2009 Feb; 28(2):132-7. PubMed ID: 19550123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of the concentration of autologous serum for generation of leukemic dendritic cells from acute myeloid leukemic cells for clinical immunotherapy.
    Choi BH; Kang HK; Park JS; Kim SK; Pham TN; Zhu XW; Cho D; Nam JH; Chung IJ; Kim YJ; Rhee JH; Kim HJ; Lee JJ
    J Clin Apher; 2006 Dec; 21(4):233-40. PubMed ID: 17120232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-4 prevents the blockade of dendritic cell differentiation induced by tumor cells.
    Menetrier-Caux C; Thomachot MC; Alberti L; Montmain G; Blay JY
    Cancer Res; 2001 Apr; 61(7):3096-104. PubMed ID: 11306493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of suppressive phenotype in monocyte-derived dendritic cells by leukemic cell products and IL-1β.
    Motta JM; Sperandio A; Castelo-Branco MT; Rumjanek VM
    Hum Immunol; 2014 Jul; 75(7):641-9. PubMed ID: 24768898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of immunostimulatory dendritic cells from human CD34+ hematopoietic progenitor cells of the bone marrow and peripheral blood.
    Bernhard H; Disis ML; Heimfeld S; Hand S; Gralow JR; Cheever MA
    Cancer Res; 1995 Mar; 55(5):1099-104. PubMed ID: 7532543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukaemia-derived dendritic cells can be generated from blood or bone marrow cells from patients with myelodysplasia: a methodological approach under serum-free culture conditions.
    Kufner S; Zitzelsberger H; Kroell T; Pelka-Fleischer R; Salem A; de Valle F; Schmid C; Schweiger C; Kolb HJ; Schmetzer HM
    Scand J Immunol; 2005 Jul; 62(1):75-85. PubMed ID: 16091127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infusion of unpulsed dendritic cells derived from granulocyte/macrophage colony-stimulating factor-mobilized peripheral blood CD34+ cells and monocytes in patients with advanced carcinoma.
    Triozzi PL; Kim J; Aldrich W
    J Hematother Stem Cell Res; 2003 Jun; 12(3):279-87. PubMed ID: 12857369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a clinical-scale method for generation of dendritic cells from PBMC for use in cancer immunotherapy.
    Wong EC; Maher VE; Hines K; Lee J; Carter CS; Goletz T; Kopp W; Mackall CL; Berzofsky J; Read EJ
    Cytotherapy; 2001; 3(1):19-29. PubMed ID: 12028840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional and phenotypic analysis of thymic CD34+CD1a- progenitor-derived dendritic cells: predominance of CD1a+ differentiation pathway.
    Dalloul AH; Patry C; Salamero J; Canque B; Grassi F; Schmitt C
    J Immunol; 1999 May; 162(10):5821-8. PubMed ID: 10229816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukemia-derived dendritic cells can be generated from blood or bone marrow cells from patients with acute myeloid leukaemia: a methodological approach under serum-free culture conditions.
    Kufner S; Zitzelsberger H; Kroell T; Pelka-Fleischer R; Salem A; de Valle F; Schweiger C; Nuessler V; Schmid C; Kolb HJ; Schmetzer HM
    Scand J Immunol; 2005 Jul; 62(1):86-98. PubMed ID: 16091128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.